标题
MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice
作者
关键词
miR-337-3p, PCSK9, LDL-C, Hyperlipidemia, Dual regulation
出版物
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 119, Issue -, Pages 154768
出版商
Elsevier BV
发表日期
2021-03-27
DOI
10.1016/j.metabol.2021.154768
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes
- (2020) Yaqiong Xu et al. ATHEROSCLEROSIS
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiR-337-3p Promotes Adipocyte Browning by Inhibiting TWIST1
- (2020) Indira G.C. Vonhögen et al. Cells
- LDL Receptor Pathway Regulation by miR-224 and miR-520d
- (2020) Alessandro G. Salerno et al. Frontiers in Cardiovascular Medicine
- miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder
- (2020) Lei Fan et al. JOURNAL OF HEPATOLOGY
- Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells
- (2019) Xiao-Ming Cao Cancer Biomarkers
- Maximizing the benefits of cholesterol-lowering drugs
- (2019) Kenneth R. Feingold CURRENT OPINION IN LIPIDOLOGY
- MicroRNA‐based regulatory circuit involved in sperm infertility
- (2019) Sara Rahbar et al. ANDROLOGIA
- Bempedoic Acid (ETC-1002)
- (2018) Anum Saeed et al. CARDIOLOGY CLINICS
- Circulating microRNAs and adipokines as markers of metabolic syndrome in adolescents with obesity
- (2018) Hadeel A. Al-Rawaf CLINICAL NUTRITION
- PCSK9: A novel inflammation modulator in atherosclerosis?
- (2018) Zhi-Han Tang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4
- (2018) Qianfeng Zhuang et al. Cancer Biomarkers
- Liver Transplantation for Homozygous Familial Hypercholesterolemia
- (2018) Yasushi Ishigaki et al. Journal of Atherosclerosis and Thrombosis
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Systemic antimiR-337-3p delivery inhibits cerebral ischemia-mediated injury
- (2017) Xiaomin Wang et al. NEUROBIOLOGY OF DISEASE
- MiR-1254 suppresses HO-1 expression through seed region-dependent silencing and non-seed interaction with TFAP2A transcript to attenuate NSCLC growth
- (2017) Mengfan Pu et al. PLoS Genetics
- Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context
- (2017) Peter P. Toth et al. JOURNAL OF MEDICAL ECONOMICS
- Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
- (2017) Parisa Naeli et al. Frontiers in Genetics
- Cholesterol Biosynthesis: A Mechanistic Overview
- (2016) Nuno M. F. S. A. Cerqueira et al. BIOCHEMISTRY
- A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1
- (2016) Lingling Miao et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- miRNA regulation of LDL-cholesterol metabolism
- (2016) Leigh Goedeke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- PCSK9 Inhibition: Current Concepts and Lessons from Human Genetics
- (2015) Fatima Rodriguez et al. Current Atherosclerosis Reports
- Impairment of Liver Glycogen Storage in the db/db Animal Model of Type 2 Diabetes: A Potential Target for Future Therapeutics?
- (2015) Mitchell Sullivan et al. CURRENT DRUG TARGETS
- Reduction of circulating PCSK9 and LDL-C levels by liver-specific knockdown of HNF1α in normolipidemic mice
- (2015) Vikram Ravindra Shende et al. JOURNAL OF LIPID RESEARCH
- MicroRNA Therapeutics: the Next Magic Bullet?
- (2015) Bridget Simonson et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- Supplementation with the Extract of Schisandrae Fructus Pulp, Seed, or Their Combination Influences the Metabolism of Lipids and Glucose in Mice Fed with Normal and Hypercholesterolemic Diet
- (2014) Xiao-Yan Wang et al. Evidence-based Complementary and Alternative Medicine
- Importin 8 Regulates the Transport of Mature MicroRNAs into the Cell Nucleus
- (2014) Yao Wei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LDL cholesterol: controversies and future therapeutic directions
- (2014) Paul M Ridker LANCET
- The pharmacology of statins
- (2014) Cesare R. Sirtori PHARMACOLOGICAL RESEARCH
- Recent advances in physiological lipoprotein metabolism
- (2013) Indra Ramasamy CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression
- (2012) G. Zardo et al. BLOOD
- Combinatorial Action of miRNAs Regulates Transcriptional and Post-Transcriptional Gene Silencing following in vivo PNS Injury
- (2012) Tadepalli Adilakshmi et al. PLoS One
- Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver
- (2011) Kirandeep Kaur et al. Molecular BioSystems
- KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
- (2011) Chen Xie et al. NUCLEIC ACIDS RESEARCH
- Advancing therapy for hypercholesterolemia
- (2010) Konstantinos Toutouzas et al. EXPERT OPINION ON PHARMACOTHERAPY
- HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk
- (2009) M.T. Cooney et al. ATHEROSCLEROSIS
- Transcriptional inhibition of Hoxd4 expression by noncoding RNAs in human breast cancer cells
- (2009) Yuliang Tan et al. BMC MOLECULAR BIOLOGY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started